Professor, Obstetrics and Gynecology, University of Washington School of Medicine
Obstetrics & Gynecology
Dr. Hisham K. Tamimi, MD
|
|
Give Review
Hisham K. Tamimi, MD works in the field of Obstetrics & Gynecology. He received 1 awards: "Fellow (FACOG)". Hisham Tamimi is a published physician. He has 71 publications published. The most current publication "Adenocarcinoma of the uterine cervix metastatic to lymph nodes." He accepts all Medicare patients.
Publications
- Recurrence patterns after extended treatment with bevacizumab for ovarian, fallopian tube, and primary peritoneal Cancers.
- FOXP3+ regulatory T-cells are abundant in vulvar Paget's disease and are Associated with recurrence.
- Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian Cancer.
- Glassy cell Carcinoma of the cervix revisited.
- Clear cell Carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease.
- Serum inhibin and disease Status in women with ovarian granulosa cell tumors.
- Intraperitoneal spread of cervical Carcinoma after laparoscopic lymphadenectomy.
- Factors influencing ototoxicity in ovarian Cancer patients treated with Cis-platinum based chemotherapy.
- The utility of immunocytochemistry in invasive adenoCarcinoma of the cervix.
- Cerebral metastases from ovarian Carcinoma.
- Supraumbilical upper abdominal midline incision for Pelvic surgery in the morbidly obese patient.
- Gynecologic radiotherapy fields defined by intraoperative measurements.
- Bone marrow involvement in epithelial ovarian Cancer by immunocytochemical assessment.
- Intraoperative electron beam therapy.
- Stage IA2 squamous Carcinoma of the cervix: difficult diagnosis and therapeutic dilemma.
- The morbidity and benefits of concurrent gracilis myocutaneous graft with Pelvic exenteration.
- Stage IB adenoCarcinoma of the cervix treated by radical hysterectomy and pelvic lymph node dissection.
- Fetal and maternal considerations in the management of stage I-B Cervical cancer during pregnancy.
- Whole abdomen radiation for minimal residual epithelial ovarian Carcinoma after surgical resection and maximal first-line chemotherapy.
- Glassy cell Carcinoma of the cervix redefined.
- Radical reirradiation for recurrent or second primary Carcinoma of the female reproductive tract.
- Malignant melanoma of the vulva: a case report of distal recurrence in a patient With a superficially invasive primary lesion.
- Adjunctive hysterectomy following radiation therapy for bulky Carcinoma of the uterine cervix: prognostic implications of tumor persistence.
- High dose para-aortic lymph node irradiation for gynecologic Cancer: technique, toxicity, and results.
- Lymphatic spread in Carcinoma of the vulva.
- Enchondromatosis (Ollier's disease) and Ovarian juvenile granulosa cell tumor.
- Adjuvant postoperative pelvic radiation for Carcinoma of the uterine cervix: pattern of cancer recurrence in patients undergoing elective radiation following radical h...
- Osteomyelitis pubis after radical gynecologic operations.
- Superficially invasive vulvar Cancer with nodal metastases.
- Treatment variables in the management of endometrial Cancer.
- Stage I vulvar Cancer: criteria for microinvasion.
- Triploid fetus and hydatidiform mole: antenatal diagnosis and cytogenetic study.
- Quality of care in women with stage I Cervical cancer.
- Patterns of recurrence of Carcinoma following radical hysterectomy.
- Femoral node metastases with negative superficial inguinal nodes in early vulvar Cancer.
- AdenoCarcinoma of the uterine tube: potential for lymph node metastases.
- Chemoprevention of Cervical cancer with folic acid: a phase III Southwest Oncology Group Intergroup study.
- The use of intraoperative radiation therapy in radical salvage for recurrent Cervical cancer: outcome and toxicity.
- Primary central nervous system recurrence after paclitaxel therapy for epithelial Ovarian malignancy.
- Reviving the pelvic examination for evaluating the Status of ovarian carcinoma.
- Expression of c-erb B-2 oncogene product in persistent gestational trophoblastic disease.
- Paclitaxel (Taxol) treatment for refractory ovarian Cancer: phase II clinical trial.
- Uterine papillary serous Carcinoma: patterns of metastatic spread.
- A retrospective review of paclitaxel-associated gastrointestinal necrosis in patients with epithelial ovarian Cancer.
- The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial Cancer.
- The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial Cancer.
- Uterine papillary serous Carcinoma: evaluation of long-term survival in surgically staged patients.
- Malignant melanoma of the vagina: a case report of progression from preexisting melanosis.
- Methotrexate compared With mercaptopurine for early induced abortion.
- Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary.
- Telomerase activation in Cervical cancer.
- Primary chorioCarcinoma of the ovary.
- Bowel complications With taxol therapy.
- Dermatofibrosarcoma proTuberans of the vulva.
- Urinary stress incontinence following radical vulvectomy: a report of two cases.
- Prognostic impact of laterality in malignant Ovarian germ cell tumors.
- Disparities in treatment and survival between African American and White women with vaginal Cancer.
- Does size matter? Tumor size and morphology as predictors of nodal Status and recurrence in endometrial cancer.
- Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of Cervical cancer: a phase I trial of the Puget Sound Oncology Consortium.
- A population-based study of squamous cell vaginal Cancer: HPV and cofactors.
- A psychoeducational intervention for sexual dysfunction in women with gynecologic Cancer.
- Impact of surgical staging in women with locally advanced Cervical cancer.
- Pretreatment scalene node biopsy in gynecologic malignancy: prudent or passé?
- The prognostic significance of radiation dose and residual tumor in the treatment of barrel-shaped endophytic cervical Carcinoma.
- Oncogene expression: long-term compared with short-term survival in patients with advanced epithelial ovarian Cancer.
- AdenoCarcinoma of the uterine cervix metastatic to lymph nodes.
- A new technique for performing Syed template interstitial implants for anterior vaginal tumors using an open retropubic approach.
- Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar Cancer.
- The expression of epidermal growth factor receptor, HER-2/Neu, p53, and Ki-67 antigen in Uterine malignant mixed mesodermal tumors and adenosarcoma.
- Phase II study of high-dose cisplatin, etoposide, and cyclophosphamide for refractory ovarian Cancer.
Schools
KASR EL AINI COLLEGE OF MEDICINE UNIVERSITY OF CAIRO
Macneal Meml Hospital
Northwestern University Med Center
Sloan Kettering Cancer Center
Procedures Preformed
- Colposcopy
- Excision of Cervix
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- Gynecologic Cancer Screening
- View All
Conditions Treated
- Asymptomatic Post-Menopausal Status
- Atrophic Vaginitis
- Carcinoma in Situ
- Cervical Cancer
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Fellow (FACOG)
Drug Facts
| NPI NUMBER | 1205916103 | |
| NPPES Provider LastName | TAMIMI | |
| NPPES Provider FirstName | HISHAM | |
| NPPES Provider ZIPCode | 98109 | |
| NPPES Provider State | WA | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 81.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1205916103 |
| Last Name Of The Provider | TAMIMI |
| First Name Of The Provider | HISHAM |
| View All |
Similar Doctors
|
|
Dr. Amy E. Bland, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William A. Peters III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Renata R. Urban, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin E. Greer, MD |
|
|
Dr. Cricket H. Davenport, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas R. Easterling, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Dan S. Veljovich, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy D. Brockmeyer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathryn F. McGonigle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracy E. Irwin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara A. Goff, MD |
|
|
Dr. Kristen A. Austin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennie Mao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diana K. Koala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth Strickland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carolyn M. Gardella, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kelley A. Hanrahan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ron E. Swensen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah H. Delatorre, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Teresa M. Patani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emily F. Roemer, MD
This Doctor is OpenDoctor Recommended.
|